76 related articles for article (PubMed ID: 33726778)
1. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat.
Lan Q; Ren Z; Chen Y; Cui G; Choi IC; Ung COL; Yu HH; Lee SM
Chin Med; 2021 Mar; 16(1):27. PubMed ID: 33726778
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial.
Liu Q; Li X; Pan Y; Liu Q; Li Y; He C; Zheng N; Wang Y; Wang H; Wang Y; Sheng L; Zhang B; Shen T; Wu G; Li H; Wang X; Zhang W; Hu Y; Zhao Y
Phytomedicine; 2024 Jul; 130():155398. PubMed ID: 38788390
[TBL] [Abstract][Full Text] [Related]
3. β-Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline-deficient diet in mice.
Huang T; Liu Y; Li H; Zhang Y; Kong D; Cui G
J Food Biochem; 2020 Jul; ():e13408. PubMed ID: 32713066
[TBL] [Abstract][Full Text] [Related]
4. Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model.
Zhao F; Zhou N; Wang JL; Zhou H; Zou LQ; Zhong WX; He J; Zheng CJ; Yan SX; Wáng YXJ
Quant Imaging Med Surg; 2020 Dec; 10(12):2307-2321. PubMed ID: 33269229
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of dopamine against non-alcoholic steatohepatitis via inhibiting p65 pathways in vivo and in vitro.
Ma P; Wang X; Wen X; Pu L; Ou Y
Toxicol Res (Camb); 2024 Jun; 13(3):tfae068. PubMed ID: 38737340
[TBL] [Abstract][Full Text] [Related]
6. Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics.
Tang N; Ji L; Shi X; Xiong Y; Xiong X; Zhao H; Song H; Wang J; Zhang L; You S; Ji G; Liu B; Wu N
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675462
[TBL] [Abstract][Full Text] [Related]
7. Expression of Concern: Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
PLOS ONE Editors
PLoS One; 2023; 18(1):e0279807. PubMed ID: 36630370
[No Abstract] [Full Text] [Related]
8. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.
Alipoor B; Nikouei S; Rezaeinejad F; Malakooti-Dehkordi SN; Sabati Z; Ghasemi H
J Endocrinol Invest; 2021 Oct; 44(10):2015-2041. PubMed ID: 33792864
[TBL] [Abstract][Full Text] [Related]
10. Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver.
Ko M; Kamimura K; Owaki T; Nagoya T; Sakai N; Nagayama I; Niwa Y; Shibata O; Oda C; Morita S; Kimura A; Inoue R; Setsu T; Sakamaki A; Yokoo T; Terai S
Dis Model Mech; 2021 Mar; 14(3):. PubMed ID: 33787507
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
Kedarisetty CK; Bhardwaj A; Kumar G; Rastogi A; Bihari C; Kumar M; Sarin SK
Indian J Gastroenterol; 2021 Feb; 40(1):41-49. PubMed ID: 33772456
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics in NAFLD/NASH: Targets and therapy.
Sodum N; Kumar G; Bojja SL; Kumar N; Rao CM
Pharmacol Res; 2021 May; 167():105484. PubMed ID: 33771699
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Caussy C; Aubin A; Loomba R
Curr Diab Rep; 2021 Mar; 21(5):15. PubMed ID: 33742318
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
[TBL] [Abstract][Full Text] [Related]
15. Public awareness and knowledge of liver health and diseases in Singapore.
Tan CK; Goh GB; Youn J; Yu JC; Singh S
J Gastroenterol Hepatol; 2021 Aug; 36(8):2292-2302. PubMed ID: 33735936
[TBL] [Abstract][Full Text] [Related]
16. Coronary artery disease and non-alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans.
Kirby RS; Halegoua-DeMarzio D
JGH Open; 2021 Mar; 5(3):390-395. PubMed ID: 33732887
[TBL] [Abstract][Full Text] [Related]
17. Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity.
Ramadan A; Khalaf AR; El Ray A; Saad Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e363-e367. PubMed ID: 33731590
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease.
Xu L; Zhou J; Che J; Wang H; Yang W; Zhou W; Zhao H
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1034-G1044. PubMed ID: 33728991
[TBL] [Abstract][Full Text] [Related]
19. The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms.
Li Z; Shen W; Wu G; Qin C; Zhang Y; Wang Y; Song G; Xiao C; Zhang X; Deng G; Wang R; Wang X
FEBS Open Bio; 2021 Jul; 11(7):1893-1906. PubMed ID: 33728819
[TBL] [Abstract][Full Text] [Related]
20. Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine.
Yamamoto K; Honda T; Yokoyama S; Ma L; Kato A; Ito T; Ishizu Y; Kuzuya T; Nakamura M; Kawashima H; Ishigami M; Tsuji NM; Fujishiro M
Dig Liver Dis; 2021 Nov; 53(11):1443-1450. PubMed ID: 33726979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
